$115.71 +2.64 (%) Gilead Sciences Inc - NASDAQ

Jul. 29, 2015 | 04:00 PM

Partner Headlines

  1. Gilead Gets Wall Street Love After Q2 Earnings Beat

    IBD | Jul. 29, 2015 | 12:29PM EST
  2. Morning Market Gainers

    Benzinga | Jul. 29, 2015 | 09:46AM EST
  3. Benzinga's Top #PreMarket Gainers

    Benzinga | Jul. 29, 2015 | 08:14AM EST
  4. Fast Money Picks For July 29

    Benzinga | Jul. 29, 2015 | 06:44AM EST
  5. 5 Hot Drug Stocks Top IBD's Big Cap Leaders Screen

    IBD | Jul. 28, 2015 | 20:07PM EST
  6. Gilead Beats, Lifts Outlook

    IBD | Jul. 28, 2015 | 18:37PM EST
  7. Stocks Post First Gain In 6 Days; Twitter, Gilead Leap On Earnings

    IBD | Jul. 28, 2015 | 16:57PM EST
  8. Tuesday's After-Hours Movers: Twitter, Gilead, Yelp And Buffalo Wild Wings

    Benzinga | Jul. 28, 2015 | 16:53PM EST
  9. Gilead Q2 Earnings Soar As HCV Shines, HIV Rebounds

    IBD | Jul. 28, 2015 | 16:34PM EST
  10. Gilead Sciences Q2 Profit Beats Views, Shares Rise

    Benzinga | Jul. 28, 2015 | 16:31PM EST
  11. Options Strategist Discusses Activity In Gilead And Wynn Ahead Of Earnings

    Benzinga | Jul. 28, 2015 | 15:50PM EST
  12. Stocks Push Ahead In Late Trade; Jazz Clears Buy Point

    IBD | Jul. 28, 2015 | 15:05PM EST
  13. Which Big-Cap Stocks Are Defying Market Pressure?

    IBD | Jul. 27, 2015 | 18:46PM EST
  14. A Big Day For Biotech And It's Not Going So Well

    Benzinga | Jul. 27, 2015 | 13:10PM EST
  15. Meet 5 IBD 50 Stocks Reporting Earnings This Week

    IBD | Jul. 25, 2015 | 10:02AM EST
  16. Gilead Sciences Leads 3 Top-Rated Big Cap Stocks

    IBD | Jul. 22, 2015 | 08:02AM EST
  17. Gilead's Fantastic Growth Expected To Slow

    IBD | Jul. 17, 2015 | 18:48PM EST
  18. It's Not Too Late To Buy Gilead Sciences

    GuruFocus | Jul. 17, 2015 | 12:01PM EST
  19. Why Big Biotech Could Have Another Leg Up

    Benzinga | Jul. 17, 2015 | 10:49AM EST
  20. Which Top Biotechs Still In Play After Celgene Rally?

    IBD | Jul. 16, 2015 | 18:45PM EST
  21. Fitbit Leads Trio Of Hot Health-Related IPO Stocks

    IBD | Jul. 15, 2015 | 17:50PM EST
  22. What Will Gilead Buy Next? 4 Possible Targets

    IBD | Jul. 15, 2015 | 16:44PM EST
  23. Celgene Hits High As Street Applauds Receptos Buyout

    IBD | Jul. 15, 2015 | 11:12AM EST
  24. Johnson & Johnson Profit Dips

    IBD | Jul. 14, 2015 | 18:54PM EST
  25. Stocks Hold On To Most Gains; Biotechs Quicken Their Pulse

    IBD | Jul. 14, 2015 | 13:19PM EST
  26. J&J Earnings Beat Views As Pharma Leads Way Again

    IBD | Jul. 14, 2015 | 11:18AM EST
  27. Fast Money Picks For July 14

    Benzinga | Jul. 14, 2015 | 06:40AM EST
  28. Big Cap 20: Biotech Red-Hot As Medicals Stay Dominant

    IBD | Jul. 13, 2015 | 18:43PM EST
  29. Don't Count Out Top Biotechs — They Still Got Game

    IBD | Jul. 10, 2015 | 18:05PM EST
  30. CNBC's Meg Tirrel Speculates About Gilead's New Acquisiton

    Benzinga | Jul. 10, 2015 | 06:52AM EST
  31. Regeneron, Amgen Downgraded As Biotech Seen Slowing

    IBD | Jul. 9, 2015 | 11:12AM EST
  32. Apple: A Top Fidelity Manager Sticks By The Stock

    IBD | Jul. 7, 2015 | 18:53PM EST
  33. Keep An Eye On These 8 After-Hours Movers

    Benzinga | Jul. 7, 2015 | 08:18AM EST
  34. Big Cap 20: Does Edwards Lifesciences Have More Left?

    IBD | Jul. 6, 2015 | 18:53PM EST
  35. Gilead Sciences is Still Undervalued

    GuruFocus | Jul. 6, 2015 | 15:02PM EST
  36. Japan's Ministry of Health, Labour and Welfare Approves Gilead's Harvoni

    Benzinga | Jul. 3, 2015 | 06:44AM EST
  37. Juno, Celgene Lead 5 Top Biotechs Nearing Buy Point

    IBD | Jul. 1, 2015 | 17:43PM EST
  38. Gilead Submits New Drug Application to U.S. Food and Drug Administration for Single Tablet Regimen for HIV Containing Rilpivirine, Emtricitabine and Tenofovir Alafenamide

    Benzinga | Jul. 1, 2015 | 16:30PM EST
  39. What Is Beyond Vision-Loss Blockbuster For Regeneron?

    IBD | Jul. 1, 2015 | 16:12PM EST
  40. Can Hepatitis B Be A Blockbuster Bug?

    IBD | Jul. 1, 2015 | 08:02AM EST
  41. Julian Robertson Discusses Greece Threat, Stocks and Apple

    GuruFocus | Jul. 1, 2015 | 00:10AM EST
  42. Why I Am Buying Gilead Sciences

    GuruFocus | Jun. 30, 2015 | 09:34AM EST
  43. Big Cap Leaders Slide As Much As 4.7%

    IBD | Jun. 29, 2015 | 19:05PM EST
  44. Biotech Short-Sellers Prefer Amgen To Gilead Sciences

    Benzinga | Jun. 27, 2015 | 18:02PM EST
  45. Can Top Stock Gilead Maintain Booming Profit Growth?

    IBD | Jun. 26, 2015 | 18:56PM EST
  46. Acquisitions May Fuel Gilead Sciences' Winning Ways

    IBD | Jun. 26, 2015 | 17:28PM EST
  47. Can Cambrex Keep Profits Healthy On Gilead Pact?

    IBD | Jun. 26, 2015 | 17:02PM EST
  48. Alan Fournier Sells Stake in Gilead Sciences

    GuruFocus | Jun. 25, 2015 | 19:05PM EST
  49. Gilead Leads 4 Top Stocks In Or Near Top Of Buy Areas

    IBD | Jun. 23, 2015 | 17:18PM EST
  50. ProShares Releases 2 New Leveraged Biotech ETFs

    Benzinga | Jun. 23, 2015 | 15:38PM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!